SecBot SecBot
144 ·Filed Apr 14, 2026

TVTX

Travere Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed7mo ago SEC0001193125-26-155628
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

Traders should not interpret this Form 144 as a negative signal; it reflects a standard tax settlement mechanism following RSU vesting, not a voluntary sale. Monitor for any additional discretionary Form 14s or Form 4s for signs of actual insider sentiment.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$40.95
T+0 close · Apr 14, 2026 · via day close
Latest settled
+38.19%
T+60 · $56.59
Vs SPY
+30.06%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 15 $40.95entry
  2. T+1 · 7mo ago −3.44%α −3.70% · $39.54
  3. T+5 · 7mo ago −2.10%α −3.74% · $40.09
  4. T+20 · 6mo ago +4.62%α −1.43% · $42.84
  5. T+60 · 4mo ago +38.19%α +30.06% · $56.59
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Elizabeth E. Reed, an officer of Travere Therapeutics, filed a Form 144 to report a mandatory 'sell to cover' transaction of 37,500 shares to satisfy tax withholding obligations following the vesting of performance-based restricted stock units. This is not a discretionary sale.

Key Facts

  • Elizabeth E. Reed, an officer, is reporting a proposed sale of 37,500 common shares.
  • The sale is a mandatory 'sell to cover' transaction to fund tax withholding obligations from vested performance restricted stock units.
  • The transaction occurred on April 14, 2026, and was not a discretionary trade by the insider.
  • Total value of the sale was approximately $1.54 million based on a share price of ~$41.07.
  • This follows a pattern of similar non-discretionary sales by the same insider over the past few months.

Financial Impact

Approximately $1.54 million in shares to be sold, representing tax-related obligations rather than insider divestment.

share countinsider ownership

Risk Factors

  • Potential misinterpretation by retail investors as a discretionary insider sale, leading to unwarranted selling pressure.
  • Continued pattern of tax-related sales could signal upcoming vesting events that may periodically increase share supply.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001193125-26-155628
Document: 0001193125-26-155628-index.html0001193125-26-155628
Document: 0001193125-26-155628.txt0001193125-26-155628

Track record

21 reports on TVTX

Performance horizon

8 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +56.24% at T+60 after the Jun 2, 2026 report. 10 of 10 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $50.30 Now $49.70 −1.19% settles Nov 23
  2. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $48.87 to $51.56 Now $49.70 +1.70% ▲ +5.50% +2.21% vs SPY
  3. Nov 3, 202613d ago Institutional Cluster Bullish 4/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
  4. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
  5. Sep 17, 20268w ago Insider Cluster Bearish 4/10 Entry $62.76 to $59.44 Now $49.70 +20.81% ▲ +5.29% +6.56% vs SPY
  6. Jul 9, 202618w ago 8-K Neutral 2/10 Entry $56.59 to $55.28 Now $49.70 −12.18% ▼ −2.31% −1.75% vs SPY
  7. Jun 16, 202621w ago Insider Cluster Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
  8. Jun 16, 202621w ago 8-K Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
  9. Jun 12, 202622w ago 144 Neutral 2/10 Entry $52.04 to $55.15 Now $49.70 −4.50% ▲ +5.98% +5.30% vs SPY
  10. Jun 2, 202623w ago 8-K Bullish 6/10 Entry $42.96 to $48.57 Now $49.70 +15.69% ▲ +13.06% +16.02% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 45m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 14, 2026